Today, a Director at Chimerix (NASDAQ: CMRX), Ernest Mario, sold shares of CMRX for $243.3K.
In addition to Ernest Mario, 2 other CMRX executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Currently, Chimerix has an average volume of 135.8K.
In the last 30 days, insiders have sold $256.2K worth of CMRX shares and purchased $54.56K worth of CMRX shares. The insider sentiment on Chimerix has been positive according to 12 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Chimerix, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.
